BDNF Gene Therapy Induces Auditory Nerve Survival and Fiber Sprouting in Deaf Pou4f3 Mutant Mice

Overview

Journal Sci Rep

Specialty Science

Date 2012 Nov 15

PMID 23150788

Citations 35

Authors

H Fukui

H T Wong

L A Beyer

B G Case

D L Swiderski

A Di Polo

A F Ryan

Y Raphael

Affiliations

Soon will be listed here.

Abstract

Current therapy for patients with hereditary absence of cochlear hair cells, who have severe or profound deafness, is restricted to cochlear implantation, a procedure that requires survival of the auditory nerve. Mouse mutations that serve as models for genetic deafness can be utilized for developing and enhancing therapies for hereditary deafness. A mouse with Pou4f3 loss of function has no hair cells and a subsequent, progressive degeneration of auditory neurons. Here we tested the influence of neurotrophin gene therapy on auditory nerve survival and peripheral sprouting in Pou4f3 mouse ears. BDNF gene transfer enhanced preservation of auditory neurons compared to control ears, in which nearly all neurons degenerated. Surviving neurons in treated ears exhibited pronounced sprouting of nerve fibers into the auditory epithelium, despite the absence of hair cells. This enhanced nerve survival and regenerative sprouting may improve the outcome of cochlear implant therapy in patients with hereditary deafness.

Citing Articles

Impact and Mechanisms of Action of BDNF on Neurological Disorders, Cancer, and Cardiovascular Diseases.

Lei M, Liu Q, Nie J, Huang R, Mei Y, Pan D CNS Neurosci Ther. 2024; 30(12):e70138.

PMID: 39648800 PMC: 11626086. DOI: 10.1111/cns.70138.

Loss of the chromatin remodeler CHD7 impacts glial cells and myelination in the mouse cochlear spiral ganglion.

Ritter K, Lynch S, Gorris A, Beyer L, Kabara L, Dolan D Hear Res. 2022; 426:108633.

PMID: 36288662 PMC: 10184650. DOI: 10.1016/j.heares.2022.108633.

BDNF Therapeutic Mechanisms in Neuropsychiatric Disorders.

Bazzari A, Bazzari F Int J Mol Sci. 2022; 23(15).

PMID: 35955546 PMC: 9368938. DOI: 10.3390/ijms23158417.

Current Concepts and Future Trends in Increasing the Benefits of Cochlear Implantation: A Narrative Review.

Blebea C, Ujvary L, Necula V, Dindelegan M, Perde-Schrepler M, Stamate M Medicina (Kaunas). 2022; 58(6).

PMID: 35744010 PMC: 9229893. DOI: 10.3390/medicina58060747.

Mechanism and Prevention of Spiral Ganglion Neuron Degeneration in the Cochlea.

Zhang L, Chen S, Sun Y Front Cell Neurosci. 2022; 15:814891.

PMID: 35069120 PMC: 8766678. DOI: 10.3389/fncel.2021.814891.

References

Jyung R, Miller J, Cannon S . Evaluation of eighth nerve integrity by the electrically evoked middle latency response. Otolaryngol Head Neck Surg. 1989; 101(6):670-82. DOI: 10.1177/019459988910100610. View

Hertzano R, Montcouquiol M, Rashi-Elkeles S, Elkon R, Yucel R, Frankel W . Transcription profiling of inner ears from Pou4f3(ddl/ddl) identifies Gfi1 as a target of the Pou4f3 deafness gene. Hum Mol Genet. 2004; 13(18):2143-53. DOI: 10.1093/hmg/ddh218. View

Xiang M, Gan L, Li D, Chen Z, Zhou L, OMalley Jr B . Essential role of POU-domain factor Brn-3c in auditory and vestibular hair cell development. Proc Natl Acad Sci U S A. 1997; 94(17):9445-50. PMC: 23217. DOI: 10.1073/pnas.94.17.9445. View

Rejali D, Lee V, Abrashkin K, Humayun N, Swiderski D, Raphael Y . Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons. Hear Res. 2007; 228(1-2):180-7. PMC: 2692458. DOI: 10.1016/j.heares.2007.02.010. View

Jahan I, Pan N, Kersigo J, Fritzsch B . Neurod1 suppresses hair cell differentiation in ear ganglia and regulates hair cell subtype development in the cochlea. PLoS One. 2010; 5(7):e11661. PMC: 2908541. DOI: 10.1371/journal.pone.0011661. View

Stankovic K, Hennessey A, Herrmann B, Mankarious L . Cochlear implantation in children with congenital X-linked deafness due to novel mutations in POU3F4 gene. Ann Otol Rhinol Laryngol. 2011; 119(12):815-22. DOI: 10.1177/000348941011901205. View

Vahava O, Morell R, Lynch E, Weiss S, Kagan M, Ahituv N . Mutation in transcription factor POU4F3 associated with inherited progressive hearing loss in humans. Science. 1998; 279(5358):1950-4. DOI: 10.1126/science.279.5358.1950. View

Rajnicek A, McCaig C . Guidance of CNS growth cones by substratum grooves and ridges: effects of inhibitors of the cytoskeleton, calcium channels and signal transduction pathways. J Cell Sci. 1998; 110 ( Pt 23):2915-24. DOI: 10.1242/jcs.110.23.2915. View

SPOENDLIN H . Innervation densities of the cochlea. Acta Otolaryngol. 1972; 73(2):235-48. DOI: 10.3109/00016487209138937. View

10.

Pauley S, Kopecky B, Beisel K, Soukup G, Fritzsch B . Stem cells and molecular strategies to restore hearing. Panminerva Med. 2008; 50(1):41-53. PMC: 2610336. View

11.

Agerman K, Hjerling-Leffler J, Blanchard M, Scarfone E, Canlon B, Nosrat C . BDNF gene replacement reveals multiple mechanisms for establishing neurotrophin specificity during sensory nervous system development. Development. 2003; 130(8):1479-91. DOI: 10.1242/dev.00378. View

12.

Shibata S, Cortez S, Beyer L, Wiler J, Di Polo A, Pfingst B . Transgenic BDNF induces nerve fiber regrowth into the auditory epithelium in deaf cochleae. Exp Neurol. 2010; 223(2):464-72. PMC: 2864331. DOI: 10.1016/j.expneurol.2010.01.011. View

13.

Puligilla C, Feng F, Ishikawa K, Bertuzzi S, Dabdoub A, Griffith A . Disruption of fibroblast growth factor receptor 3 signaling results in defects in cellular differentiation, neuronal patterning, and hearing impairment. Dev Dyn. 2007; 236(7):1905-17. PMC: 3904742. DOI: 10.1002/dvdy.21192. View

14.

Lustig L, Yeagle J, Driscoll C, Blevins N, Francis H, Niparko J . Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma. Otol Neurotol. 2006; 27(4):512-8. DOI: 10.1097/01.mao.0000217351.86925.51. View

15.

Wise A, Richardson R, Hardman J, Clark G, OLeary S . Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3. J Comp Neurol. 2005; 487(2):147-65. DOI: 10.1002/cne.20563. View

16.

Tessarollo L, Coppola V, Fritzsch B . NT-3 replacement with brain-derived neurotrophic factor redirects vestibular nerve fibers to the cochlea. J Neurosci. 2004; 24(10):2575-84. PMC: 3901528. DOI: 10.1523/JNEUROSCI.5514-03.2004. View

17.

Chikar J, Colesa D, Swiderski D, Di Polo A, Raphael Y, Pfingst B . Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons. Hear Res. 2008; 245(1-2):24-34. PMC: 2654221. DOI: 10.1016/j.heares.2008.08.005. View

18.

Raphael Y, Altschuler R . Structure and innervation of the cochlea. Brain Res Bull. 2003; 60(5-6):397-422. DOI: 10.1016/s0361-9230(03)00047-9. View

19.

Lee H, Park H, Lee K, Park R, Kim U . A novel frameshift mutation of POU4F3 gene associated with autosomal dominant non-syndromic hearing loss. Biochem Biophys Res Commun. 2010; 396(3):626-30. DOI: 10.1016/j.bbrc.2010.04.132. View

20.

Yang T, Kersigo J, Jahan I, Pan N, Fritzsch B . The molecular basis of making spiral ganglion neurons and connecting them to hair cells of the organ of Corti. Hear Res. 2011; 278(1-2):21-33. PMC: 3130837. DOI: 10.1016/j.heares.2011.03.002. View